1. Dashboard

DaVita NYSE: DVA

Invest Fact Sheet

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG).

Name DaVita
Ticker DVA
Exchange NYSE
Sector Health Care
Industry Kidney Failure
Price
52W Low/High 		107.46
72.41 / 123.89
Momentum Neutral
Market cap 12 B
1Y Total Return 39.89%
Below Average
1Y Volatility 31.50%
Less Risk
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG).

Details

Ticker DVA
Name DaVita
ISIN US23918K1088
CUSIP 23918K108
Exchange NYSE
Sector Health Care
Industry Kidney Failure
Country USA
Currency U.S. Dollar

Share as of 4/13/21

Close Price 107.46
52W Low/High 72.41 / 123.89
Market cap 12 B
1Y Total Return 39.89%
Below Average
1Y Volatility 31.50%
Less Risk
Beta 1.54
PE (trailing) 17.03
Below Average
12M Dividends -
Last Dividend Date -
Dividend Yield -

Fin. Strength

Net Profit Margin 6.7%
Cash from Op. / Cur. Liabilities 0.80
Diluted Earnings / Share 6.31
ROE 44.0%
ROIC 7.1%
Price / Revenue 1.1
Price / Book 9.5
Price / CF 6.7
Current Ratio 1.3
Cur.Liabilities / Tot.Liabilities 0.2
Financial Leverage 8.09
in Mils USD
rolling-year up to December
 
Income Statement 2020 2019 2018 2017 2016 2015  
Revenue
11,551
11,388
11,405
10,877
10,707
9,982
Gross Profit
3,562
3,474
3,209
3,237
3,276
3,126
R&D
0
0
0
0
0
0
EBITDA
2,022
2,150
1,496
2,196
2,446
1,524
Operating Income
1,668
1,631
1,530
1,821
2,013
1,123
Net Income exc. Extra
774
811
159
664
880
270
per Share  
Diluted avg Shares
123
154
172
191
205
216
EPS exc. Extra
6.31
5.27
0.92
3.47
4.29
1.25
Dividend
-
-
-
-
-
-
  
Div. Yield (an.)
-
-
-
-
-
-
  
Balance Sheet 2020 2019 2018 2017 2016 2015  
Total Assets
16,989
17,311
19,110
18,975
18,756
18,515
Cash, Eq & Invt ShortTerm
522
1,220
418
552
982
1,907
Total Current Assets
3,149
3,690
8,424
8,771
3,995
4,503
Total Non-Current Assets
13,840
13,621
10,686
10,204
14,761
14,012
Intangibles
7,086
6,923
6,961
6,724
6,089
10,982
Total Liabilities
14,092
13,812
14,077
13,077
12,933
12,567
Total Current Liabilities
2,476
2,372
4,891
3,068
2,711
2,399
Long Term Debt
11,616
11,440
9,186
10,010
10,222
10,167
Shareholder equity
1,384
2,133
3,703
4,690
4,648
4,871
Cash Flow 2020 2019 2018 2017 2016 2015  
Cash from Operations
1,979
2,072
1,772
1,913
1,972
1,557
Depreciation
630
615
591
777
720
638
Cash from Investing
-825
2,995
-1,006
-1,365
-1,202
-882
Capex
675
767
987
905
829
708
Cash from Financing
-1,847
-4,696
-625
-766
-1,352
-139
Stock Issued
-1,459
-2,372
-1,148
-782
-1,074
-524
Debt (LT) Issued
-64
-1,995
700
155
-125
543
Free Cash Flow
1,652
-2,912
2,089
1,383
1,686
82
Ratios 2020 2019 2018 2017 2016 2015  
Net Profit Margin
6.7%
7.1%
1.4%
6.1%
8.2%
2.7%
  
NCFO / Op.Income
118.7%
127.1%
115.8%
105.0%
98.0%
138.7%
  
Current Ratio
1.3
1.6
1.7
2.9
1.5
1.9
  
Financial Leverage D/E
8.09
5.24
2.73
1.99
1.96
1.87
  
Return on Capital Avg
7.1%
3.7%
4.6%
6.9%
1.1%
5.0%
  
Return on Shareholder Equity
44.0%
27.8%
3.8%
14.2%
18.5%
5.4%
  

Data

Fundamentals

More Info

No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available